Literature DB >> 22430250

Type I interferons in regulation of mucosal immunity.

Niamh E Mangan1, Ka Yee Fung.   

Abstract

The mucosal system is the first line of defense against many pathogens. It is continuously exposed to dietary and microbial antigens, and thus the host must maintain a homeostatic environment between commensal microbiota and pathogenic infections. Following infections and inflammatory events, a rapid innate immune response is evoked to dampen the inflammatory processes. Type I interferons, a family of pleiotropic cytokines and major products of the innate immune response, have a key role in these early immune events at the mucosa, as reviewed here. With the emergence of new discoveries of immune cell types in mucosal tissues and their reactions to commensal and pathogenic organisms, we also review the opportunities for exciting research in this field.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430250     DOI: 10.1038/icb.2012.13

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  9 in total

1.  Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Audrey Lasri; Ning Li; Daniel P Beiting; Amy C Durham; Ting Yang; Eli Pikarsky; Christopher J Lengner; F Brad Johnson; Yinon Ben-Neriah; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2016-01-25       Impact factor: 4.272

2.  Diagnosis and treatment of herpangina: Chinese expert consensus.

Authors:  Hui Yu; Xing-Wang Li; Quan-Bo Liu; Hui-Ling Deng; Gang Liu; Rong-Meng Jiang; Ji-Kui Deng; Ying-Zi Ye; Jian-Hua Hao; Ying-Hu Chen; Guang-Min Nong; Zhao-Bo Shen; Chang-Shan Liu; Ying-Xue Zou; Jin-Zhun Wu; Xing-Dong Wu; Bi-Quan Chen; Ru-Ping Luo; Ai-Wei Lin; Yan Chen; Xiao-Dong Liu
Journal:  World J Pediatr       Date:  2019-07-25       Impact factor: 9.186

3.  Early type I Interferon response induces upregulation of human β-defensin 1 during acute HIV-1 infection.

Authors:  Björn Corleis; Antonella C Lisanti; Christian Körner; Abigail E Schiff; Eric S Rosenberg; Todd M Allen; Marcus Altfeld; Douglas S Kwon
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

4.  Cyclophosphamide Treatment Mimics Sub-Lethal Infections With Encephalitozoon intestinalis in Immunocompromised Individuals.

Authors:  Maria Lucia Costa de Moura; Anuska Marcelino Alvares-Saraiva; Elizabeth Cristina Pérez; José Guilherme Xavier; Diva Denelle Spadacci-Morena; Carla Renata Serantoni Moysés; Paulo Ricardo Dell'Armelina Rocha; Maria Anete Lallo
Journal:  Front Microbiol       Date:  2019-09-25       Impact factor: 5.640

5.  The Pharmacologically Active Alkaloid Cryptolepine Activates a Type 1 Interferon Response That Is Independent of MAVS and STING Pathways.

Authors:  Seth A Domfeh; Patrick W Narkwa; Osbourne Quaye; Kwadwo A Kusi; Bright S Addy; Sian Lant; Rebecca P Sumner; Carlos Maluquer de Motes; Gordon A Awandare; Charles Ansah; Mohamed Mutocheluh
Journal:  J Immunol Res       Date:  2022-07-26       Impact factor: 4.493

Review 6.  Gut Barrier Damage and Gut Translocation of Pathogen Molecules in Lupus, an Impact of Innate Immunity (Macrophages and Neutrophils) in Autoimmune Disease.

Authors:  Awirut Charoensappakit; Kritsanawan Sae-Khow; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

7.  Antiviral responses by Swine primary bronchoepithelial cells are limited compared to human bronchoepithelial cells following influenza virus infection.

Authors:  Mary J Hauser; Daniel Dlugolenski; Marie R Culhane; David E Wentworth; S Mark Tompkins; Ralph A Tripp
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

8.  Mouse superkiller-2-like helicase DDX60 is dispensable for type I IFN induction and immunity to multiple viruses.

Authors:  Delphine Goubau; Annemarthe G van der Veen; Probir Chakravarty; Rongtuan Lin; Neil Rogers; Jan Rehwinkel; Safia Deddouche; Ian Rosewell; John Hiscott; Caetano Reis e Sousa
Journal:  Eur J Immunol       Date:  2015-10-12       Impact factor: 5.532

Review 9.  The Dual Nature of Type I and Type II Interferons.

Authors:  Amanda J Lee; Ali A Ashkar
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.